Clinical Trial

Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease

Study acronym: SQUARE PD
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if people who do not respond to one treatment (either behavioral or drug treatment) will respond to combined treatment. The investigators also want to find out what factors influence whether someone responds to the treatments.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-09-18; most recent amendment 2026-07-20.
Trial Details
NCT Number NCT07187466
Lead Sponsor VA Office of Research and Development
Conditions Overactive Bladder, Parkinson Disease
Enrollment 146 participants
Start Date 2026-10-01
Primary Completion 2030-03-31 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22